1. Home
  2. NGS vs ALLO Comparison

NGS vs ALLO Comparison

Compare NGS & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGS
  • ALLO
  • Stock Information
  • Founded
  • NGS 1998
  • ALLO 2017
  • Country
  • NGS United States
  • ALLO United States
  • Employees
  • NGS N/A
  • ALLO N/A
  • Industry
  • NGS Oilfield Services/Equipment
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NGS Energy
  • ALLO Health Care
  • Exchange
  • NGS Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • NGS 305.2M
  • ALLO 252.9M
  • IPO Year
  • NGS 2002
  • ALLO 2018
  • Fundamental
  • Price
  • NGS $27.27
  • ALLO $1.18
  • Analyst Decision
  • NGS Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • NGS 3
  • ALLO 10
  • Target Price
  • NGS $33.67
  • ALLO $8.88
  • AVG Volume (30 Days)
  • NGS 48.8K
  • ALLO 2.9M
  • Earning Date
  • NGS 11-13-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • NGS 1.46%
  • ALLO N/A
  • EPS Growth
  • NGS 33.85
  • ALLO N/A
  • EPS
  • NGS 1.42
  • ALLO N/A
  • Revenue
  • NGS $164,109,000.00
  • ALLO N/A
  • Revenue This Year
  • NGS $9.86
  • ALLO N/A
  • Revenue Next Year
  • NGS $14.21
  • ALLO $100.00
  • P/E Ratio
  • NGS $19.25
  • ALLO N/A
  • Revenue Growth
  • NGS 14.77
  • ALLO N/A
  • 52 Week Low
  • NGS $16.73
  • ALLO $0.86
  • 52 Week High
  • NGS $29.74
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • NGS 61.86
  • ALLO 54.14
  • Support Level
  • NGS $26.25
  • ALLO $1.09
  • Resistance Level
  • NGS $26.89
  • ALLO $1.17
  • Average True Range (ATR)
  • NGS 0.72
  • ALLO 0.07
  • MACD
  • NGS 0.05
  • ALLO 0.01
  • Stochastic Oscillator
  • NGS 89.78
  • ALLO 57.14

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: